# Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

> **NCT04388904** · PHASE4 · COMPLETED · sponsor: **The Crofoot Research Center, Inc.** · enrollment: 75 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (FDC)

## Key facts

- **NCT ID:** NCT04388904
- **Lead sponsor:** The Crofoot Research Center, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2024-04-05
- **Final completion:** 2024-04-05
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04388904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04388904, "Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04388904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*